Latest news

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense oligonucleotide licensed from Ionis Pharmaceuticals, marking a milestone in the...
Insights

Real-Time Commercial Intelligence in Life Sciences

Executive Summary Pharmaceutical commercial teams are operating in markets where competitive activity, treatment preferences, access conditions, and customer expectations can...
Insights

Top 10 AI Skills Every Life Sciences Leader Needs

Executive Summary Artificial intelligence is reshaping drug discovery, clinical development, manufacturing, regulatory operations, and Medical Affairs. As adoption expands, life...
Insights

Digital Therapeutics 2.0: The Next Phase of Software-Based Treatment

Executive Summary Digital therapeutics (DTx) are evolving beyond standalone software interventions toward more personalized, connected, and clinically integrated treatment experiences....
Commercial

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

AstraZeneca will pay insitro $40 million upfront to use...
Commercial

Merck to Acquire Silence Therapeutics for $1.3 Billion, Adding Experimental Blood Cancer Therapy

Merck KGaA, Darmstadt, Germany, has entered into a definitive...
Manufacturing

GSK promises to invest $800 million to expand Pennsylvania’s capacity to produce biologics

GSK will spend over $800 million developing an Innovation and Manufacturing facility in Pennsylvania. Filling the funds will help...
Insights

Top 10 Advances in Protein Engineering

Executive Summary Protein engineering is expanding the range of molecules scientists can design, optimize, and manufacture for pharmaceutical, biotechnology, industrial,...
Insights

Top 10 Supply Chain Innovations in Life Sciences

Executive Summary Life sciences supply chains are becoming more complex as pharmaceutical companies manage biologics, cell and gene therapies, temperature-sensitive...
Insights

Patient-Centric Clinical Development

Executive Summary Patient-centric clinical development places patients’ needs, experiences, and...
Clinical

Vanda Puts Social Anxiety Program on Hold After Asset Fails Phase 3 Study

Vanda Pharmaceuticals has suspended development of its experimental social...
Clinical

Tortugas Neuroscience Reports Positive Phase 2b Results for Schizophrenia Drug

Tortugas Neuroscience has reported positive Phase 2b trial results for obuprazine, an investigational schizophrenia treatment licensed from China’s Hansoh...
Insights

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies think about the economics of clinical research. Traditional trials often require...
Insights

Top 10 AI Investments Delivering the Highest ROI in Pharma

Executive Summary Artificial intelligence (AI) is becoming a strategic investment priority for pharmaceutical companies seeking to improve productivity, accelerate drug...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Gilead Veklury receives WHO endorsement for treatment of Covid-19

Gilead Sciences is a biopharmaceutical company with operations across...
Commercial

Lilly Licenses Hanmi’s Phase 2 GLP-2 Drug for Short Bowel Syndrome in Deal Worth Up to $1.26 Billion

Eli Lilly has entered a licensing agreement with South...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Insights

Real-Time Commercial Intelligence in Life Sciences

Executive Summary Pharmaceutical commercial teams are operating in markets where...
Insights

Top 10 AI Skills Every Life Sciences Leader Needs

Executive Summary Artificial intelligence is reshaping drug discovery, clinical development,...
Insights

Digital Therapeutics 2.0: The Next Phase of Software-Based Treatment

Executive Summary Digital therapeutics (DTx) are evolving beyond standalone software...
Clinical

Disc Medicine’s Bitopertin Meets Phase 3 Goals in Rare Sunlight-Sensitivity Disorder

Disc Medicine has reported that its experimental drug bitopertin...

Research & Development

Market Access

Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Insights

Top 10 AI Skills Every Life Sciences Leader Needs

Executive Summary Artificial intelligence is reshaping drug discovery, clinical development,...
Editorial Team -